- Home
- BHAT vs IMNN Comparison
BHAT vs IMNN Comparison
Compare BHAT & IMNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BHAT
- IMNN
- Stock Information
- Founded
- BHAT 2010
- IMNN 1982
- Country
- BHAT China
- IMNN United States
- Employees
- BHAT N/A
- IMNN N/A
- Industry
- BHAT Recreational Games/Products/Toys
- IMNN Biotechnology: Pharmaceutical Preparations
- Sector
- BHAT Consumer Discretionary
- IMNN Health Care
- Exchange
- BHAT Nasdaq
- IMNN Nasdaq
- Market Cap
- BHAT 10.3M
- IMNN 12.1M
- IPO Year
- BHAT 2019
- IMNN 1985
- Fundamental
- Price
- BHAT $1.84
- IMNN $0.56
- Analyst Decision
- BHAT
- IMNN Buy
- Analyst Count
- BHAT 0
- IMNN 2
- Target Price
- BHAT N/A
- IMNN $14.00
- AVG Volume (30 Days)
- BHAT 158.9K
- IMNN 3.8M
- Earning Date
- BHAT 04-30-2025
- IMNN 08-13-2025
- Dividend Yield
- BHAT N/A
- IMNN N/A
- EPS Growth
- BHAT N/A
- IMNN N/A
- EPS
- BHAT N/A
- IMNN N/A
- Revenue
- BHAT $18,724,190.00
- IMNN N/A
- Revenue This Year
- BHAT N/A
- IMNN N/A
- Revenue Next Year
- BHAT N/A
- IMNN N/A
- P/E Ratio
- BHAT N/A
- IMNN N/A
- Revenue Growth
- BHAT N/A
- IMNN N/A
- 52 Week Low
- BHAT $1.61
- IMNN $0.37
- 52 Week High
- BHAT $106.00
- IMNN $3.65
- Technical
- Relative Strength Index (RSI)
- BHAT 50.96
- IMNN 38.57
- Support Level
- BHAT $1.68
- IMNN $0.48
- Resistance Level
- BHAT $1.85
- IMNN $0.80
- Average True Range (ATR)
- BHAT 0.10
- IMNN 0.08
- MACD
- BHAT 0.01
- IMNN -0.01
- Stochastic Oscillator
- BHAT 65.71
- IMNN 29.00
About BHAT Blue Hat Interactive Entertainment Technology
Blue Hat Interactive Entertainment Technology is a producer, developer, and operator of augmented reality (AR) interactive entertainment games and toys in China, including interactive educational materials, mobile games, and toys with mobile game features. The company's products include AR Racer, AR Crazy Bug, AR 3D Magic Box, AR Dinosaur, Talking Tom and Friends Bouncing Bubble, and Immersive Education Classes. The company reports in the following segments: Interactive toys - animation series, Interactive toys - game series, and Mobile games, Information services, and Communication services, out of which the majority of the revenue is generated from the game series. The majority of its revenues are generated in China.
About IMNN Imunon Inc.
Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across various human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. Its clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer that has completed Phase II clinical studies. Additionally, the Company has entered a first-in-human study of its COVID-19 booster vaccine (IMNN-101).